Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.

Saved in:
Bibliographic Details
Title: Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects.
Authors: Uebelhack R; analyze & realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany., Bongartz U; analyze & realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany., Seibt S; analyze & realize GmbH, Waldseeweg 6, 13467 Berlin, Germany., Bothe G; analyze & realize GmbH, Waldseeweg 6, 13467 Berlin, Germany., Chong PW; Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia., De Costa P; InQpharm Group Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia., Wszelaki N; Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia.
Source: Journal of obesity [J Obes] 2019 Feb 03; Vol. 2019, pp. 3412952. Date of Electronic Publication: 2019 Feb 03 (Print Publication: 2019).
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 101526295 Publication Model: eCollection Cited Medium: Internet ISSN: 2090-0716 (Electronic) Linking ISSN: 20900708 NLM ISO Abbreviation: J Obes Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2090-0716
DOI:10.1155/2019/3412952